Literature DB >> 2990625

Epstein-Barr virus transformed lymphoid cell lines as a new model system in culture for the study of GM2-gangliosidoses: Tay-Sachs and Sandhoff diseases.

A Maret, R Salvayre, A Negre, J C Bes, L Douste-Blazy.   

Abstract

Epstein-Barr Virus transformed cell lines (LCL) were established from blood B-lymphocytes of patients affected with GM2-gangliosidoses variant O (Sandhoff disease, SD) and variant B (Tay-Sachs disease, TSD). LCL from SD showed a severe deficiency of activity of the major lysosomal beta-N-acetylhexosaminidase isoenzymes, Hex A and B; the residual activity was due to Hex S and Hex C. In LCL from TSD, the whole Hex activity was not deficient but isoenzyme composition was completely abnormal. Ultrastructural investigations showed the presence of pleiomorphic enlarged lysosomes appearing as clear vacuoles containing a finely fibrillo-granular material characteristic of the visceral lysosomal storage of gangliosidoses.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990625     DOI: 10.1111/j.1768-322x.1985.tb00376.x

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  3 in total

1.  Feasibility of using cryopreserved lymphoblastoid cells to diagnose some lysosomal storage diseases.

Authors:  A S de Mello; F Provin; K Michelin-Tireli; M V Camelier; J C Coelho
Journal:  Cell Prolif       Date:  2010-04       Impact factor: 6.831

2.  Epstein-Barr virus-induced transformation of B cells for the diagnosis of genetic metabolic disorders--enumerative conditions for cryopreservation.

Authors:  A S Mello; M G Burin; K Michellin; M Viapiana; R Giugliani; J C Coelho; M E Bauer
Journal:  Cell Prolif       Date:  2006-02       Impact factor: 6.831

3.  Effect of one year of cryopreservation on the activity of lysosomal hydrolases from EBV-transformed lymphocytes.

Authors:  A S de Mello; F B Mendes; K Michelin-Tireli; M V Camelier; J C Coelho
Journal:  J Biomed Biotechnol       Date:  2011-05-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.